New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients

被引：132

作者：

Ribeiro, Isabela ^{[1
]}

Sevcsik, Ann-Marie ^{[1
]}

Alves, Fabiana ^{[1
]}

Diap, Graciela ^{[1
]}

Don, Robert ^{[1
]}

Harhay, Michael O. ^{[2
]}

Chang, Shing ^{[1
]}

Pecoul, Bernard ^{[1
]}

机构：

[1] Drugs Neglected Dis Initiat, Geneva, Switzerland

[2] Univ Penn, Sch Med, Masters Publ Hlth Program, Philadelphia, PA 19104 USA

来源：

PLOS NEGLECTED TROPICAL DISEASES | 2009年 / 3卷 / 07期

关键词：

STEROL 14-DEMETHYLASE INHIBITORS; NEGLECTED TROPICAL DISEASES; TRYPANOSOMA-CRUZI; LATIN-AMERICA; IN-VITRO; BENZNIDAZOLE; DRUG; CHEMOTHERAPY; CARDIOMYOPATHY; TRANSMISSION;

D O I：

10.1371/journal.pntd.0000484

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页数：6

共 58 条

[41]

REMME JHF, 2006, TROPICAL DIS TARGETE, P433

[42] Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection) [J].

Reyes, P. A. ;

Vallejo, M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04)

[43] Safety of the blood supply in Latin America [J].

Schmunis, GA ;

Cruz, JR .

CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (01) :12-+

[44] Epidemiology of Chagas disease in non-endemic countries: the role of international migration [J].

Schmunis, Gabriel A. .

MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2007, 102 :75-85

[45] Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function [J].

Schormann, N. ;

Senkovich, O. ;

Walker, K. ;

Wright, D. L. ;

Anderson, A. C. ;

Rosowsky, A. ;

Ananthan, S. ;

Shinkre, B. ;

Velu, S. ;

Chattopadhyay, D. .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (04) :889-901

[46] Kinetic characterization of squalene synthase from Trypanosoma cruzi:: Selective inhibition by quinuclidine derivatives [J].

Sealey-Cardona, Marco ;

Cammerer, Simon ;

Jones, Simon ;

Ruiz-Perez, Luis M. ;

Brun, Reto ;

Gilbert, Ian H. ;

Urbina, Julio A. ;

Gonzalez-Pacanowska, Dolores .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2123-2129

[47] Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase [J].

Szajnman, SH ;

Ravaschino, EL ;

Docampo, R ;

Rodriguez, JB .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) :4685-4690

[48] The challenges of chagas disease -: Grim outlook or glimmer of hope? [J].

Tarleton, Rick L. ;

Reithinger, Richard ;

Urbina, Julio A. ;

Kitron, Uriel ;

Gurtler, Ricardo E. .

PLOS MEDICINE, 2007, 4 (12) :1852-1857

[49] Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187.: Activity against drug-resistant Trypanosoma cruzi strains [J].

Urbina, JA ;

Payares, G ;

Sanoja, C ;

Molina, J ;

Lira, R ;

Brener, Z ;

Romanha, AJ .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) :39-48

[50] In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease [J].

Urbina, JA ;

Payares, G ;

Sanoja, C ;

Lira, R ;

Romanha, AJ .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) :27-38

← 1 2 3 4 5 6 →